State of Tennessee Department of Treasury Has $372,000 Holdings in ProAssurance Co. (NYSE:PRA)

State of Tennessee Department of Treasury boosted its holdings in shares of ProAssurance Co. (NYSE:PRA) by 15.8% in the fourth quarter, HoldingsChannel reports. The firm owned 23,386 shares of the insurance provider’s stock after acquiring an additional 3,191 shares during the period. State of Tennessee Department of Treasury’s holdings in ProAssurance were worth $372,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of PRA. Wealthfront Advisers LLC acquired a new stake in shares of ProAssurance in the fourth quarter valued at $359,000. Amundi increased its position in ProAssurance by 182.3% in the 4th quarter. Amundi now owns 25,634 shares of the insurance provider’s stock valued at $389,000 after acquiring an additional 16,552 shares in the last quarter. Prudential Financial Inc. raised its stake in shares of ProAssurance by 57.3% in the fourth quarter. Prudential Financial Inc. now owns 86,703 shares of the insurance provider’s stock worth $1,379,000 after acquiring an additional 31,580 shares during the last quarter. American Century Companies Inc. raised its stake in shares of ProAssurance by 17.2% in the fourth quarter. American Century Companies Inc. now owns 391,609 shares of the insurance provider’s stock worth $6,230,000 after acquiring an additional 57,556 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of ProAssurance by 28.0% during the fourth quarter. JPMorgan Chase & Co. now owns 323,955 shares of the insurance provider’s stock worth $5,154,000 after purchasing an additional 70,780 shares in the last quarter. Institutional investors own 85.58% of the company’s stock.

ProAssurance Stock Down 0.1 %

NYSE:PRA opened at $23.01 on Monday. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance Co. has a 12-month low of $10.76 and a 12-month high of $23.70. The stock’s fifty day simple moving average is $20.74 and its 200-day simple moving average is $17.42. The firm has a market capitalization of $1.18 billion, a P/E ratio of 27.72 and a beta of -0.09.

ProAssurance (NYSE:PRA) last posted its earnings results on Monday, February 24th. The insurance provider reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.19. The company had revenue of $287.52 million during the quarter, compared to analyst estimates of $274.56 million. ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. Equities research analysts expect that ProAssurance Co. will post 0.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on PRA shares. Citigroup cut shares of ProAssurance to a “market perform” rating in a research report on Thursday, April 3rd. Citizens Jmp lowered ProAssurance from an “outperform” rating to a “market perform” rating in a research note on Thursday, April 3rd. StockNews.com began coverage on ProAssurance in a research report on Saturday. They issued a “hold” rating for the company. Finally, Raymond James downgraded shares of ProAssurance from a “market perform” rating to an “underperform” rating in a research report on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, ProAssurance currently has a consensus rating of “Hold” and an average price target of $18.67.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.